NMDA receptor/L-VGCC-dependent expression and AMPA/KA receptor-dependent activation of c-Jun induced by cerebral ischemia in rat hippocampus

Neuroscience Letters

Volumn 398, Issue 3, 2006, Pages 268-273

  Zhang, Quan Guang ^a   Xu, Yong Ling ^a   Li, Hong Chun ^a   Han, Dong ^a   Zhang, Guang Yi ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AMPA KA receptor; Antagonist; c Jun; Cerebral ischemia; L Type voltage gated Ca2+ channel; NMDA receptor; Rat

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; IONOTROPIC RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIFEDIPINE; STRESS ACTIVATED PROTEIN KINASE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; GEL MOBILITY SHIFT ASSAY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CAROTID STENOSIS; ENZYME ACTIVATION; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KETAMINE; MALE; NIFEDIPINE; PHOSPHORYLATION; PROTEIN BINDING; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; REPERFUSION; TRANSCRIPTION FACTOR AP-1;

EID: 33646366181     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.01.005     Document Type: Article

References (24)

1. Azuma Y., Ogita K., and Yoneda Y. Particular nuclear transcription factors responsive to systemic administration of kainic acid in murine brain. Neurochem. Int. 29 (1996) 289-299
2. Bading H., Ginty D.D., and Greenberg M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260 (1993) 181-186
3. Bleakman D., and Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 37 (1998) 1187-1204
4. Collaco-Moraes Y., Aspey B.S., de Belleroche J.S., and Harrison M.J. Focal ischemia causes an extensive induction of immediate early genes that are sensitive to MK-801. Stroke 25 (1994) 1855-1860 (discussion 1861)
5. Fiore R.S., Murphy T.H., Sanghera J.S., Pelech S.L., and Baraban J.M. Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J. Neurochem. 61 (1993) 1626-1633
6. Ham J., Eilers A., Whitfield J., Neame S.J., and Shah B. c-Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60 (2000) 1015-1021
7. Hou Y.N., Cebers G., Terenius L., and Liljequist S. Characterization of NMDA- and AMPA-induced enhancement of AP-1 DNA binding activity in rat cerebellar granule cells. Brain Res. 754 (1997) 79-87
8. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270 (1995) 16483-16486
9. Lee J.M., Zipfel G.J., and Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature 399 (1999) A7-A14
10. Liu H.N., Giasson B.I., Mushynski W.E., and Almazan G. AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain and caspase 3. J. Neurochem. 82 (2002) 398-409
11. McGahan L., Hakim A.M., Nakabeppu Y., and Robertson G.S. Ischemia-induced CA1 neuronal death is preceded by elevated FosB and Jun expression and reduced NGFI-A and JunB levels. Mol. Brain Res. 56 (1998) 146-161
12. Morley P., Hogan M.J., and Hakim A.M. Calcium-mediated mechanisms of ischemic injury and protection. Brain Pathol. 4 (1994) 37-47
13. Ogita K., and Yoneda Y. Selective potentiation of DNA binding activities of both activator protein 1 and cyclic AMP response element binding protein through in vivo activation of N-methyl-d-aspartate receptor complex in mouse brain. J. Neurochem. 63 (1994) 525-534
14. Savinainen A., Garcia E.P., Dorow D., Marshall J., and Liu Y.F. Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95. J. Biol. Chem. 276 (2001) 11382-11386
15. Seeburg P.H. The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16 (1993) 359-365
16. Sheng M., Dougan S.T., McFadden G., and Greenberg M.E. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell Biol. 8 (1988) 2787-2796
17. Soriano M.A., Ferrer I., Rodriguez-Farre E., and Planas A.M. Apoptosis and c-Jun in the thalamus of the rat following cortical infarction. Neuroreport 7 (1996) 425-428
18. Thomson S., Mahadevan L.C., and Clayton A.L. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin. Cell Dev. Biol. 10 (1999) 205-214
19. Tian H., Zhang G., Li H., and Zhang Q. Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus. Neurosci. Res. 46 (2003) 191-197
20. Tian H., Zhang Q.G., Zhu G.X., Pei D.S., Guan Q.H., and Zhang G.Y. Activation of c-Jun NH2-terminal kinase 3 is mediated by the GluR6.PSD-95.MLK3 signaling module following cerebral ischemia in rat hippocampus. Brain Res. 1061 (2005) 57-66
21. Watson A., Eilers A., Lallemand D., Kyriakis J., Rubin L.L., and Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18 (1998) 751-762
22. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
23. Zhang G.Y., and Zhang Q.G. Agents targeting c-Jun N-terminal kinase pathway as potential neuroprotectants. Expert Opin. Invest. Drugs 14 (2005) 1373-1383
24. 2+-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors involving oxidative stress following brain ischemia in rat hippocampus. Neurosci. Lett. 337 (2003) 51-55